Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in treatment-experienced cirrhotic genotype 1 HCV
NCT01965535Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Oct 2013; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01965535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965535.